Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2021 · 10-Q
Revenue$237.42M$237.42M−0.3% vs Q2 2020 Net Income$44.59M$44.59M+34.1% vs Q2 2020 EPS Diluted$0.88$0.88+35.4% vs Q2 2020 Gross Profit$137,661,000+0.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$52,139,000+3.8% Free Cash Flowderived$43,073,000−7.1% Margins · derivedGross margin58.0%+0.5 pt vs Q2 2020
Operating margin30.7%+1.6 pt vs Q2 2020
Net margin18.8%+4.8 pt vs Q2 2020
ended Sep 30, 2020 · filed Nov 5, 2020 · 36 d after period end